Default: Chirality

ISSN: 0899-0042

Journal Home

Journal Guideline

Chirality Q3 Unclaimed

Wiley-Liss Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Chirality is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 81. It has a price of 2500 €. It has an SJR impact factor of 0,382 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,382.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

2500 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Chirality

0,382

SJR Impact factor

81

H Index

119

Total Docs (Last Year)

303

Total Docs (3 years)

6056

Total Refs

615

Total Cites (3 years)

301

Citable Docs (3 years)

2.1

Cites/Doc (2 years)

50.89

Ref/Doc

Comments

No comments ... Be the first to comment!



Best articles by citations

Steric aspects of formoterol and terbutaline: Is there an adverse effect of the distomer on airway smooth muscle function?

View more

Preparative resolution of 1-aminoindan-1,5-dicarboxylic acid (AIDA) by chiral ligand-exchange chromatography

View more

Book Review

View more

Convenient lipase-assisted preparation of both enantiomers of suprofen, a non-steroidal anti-inflammatory drug

View more

Chiral aldehydes in hydrocarbons: diastereoselective nucleophilic addition, NMR, and CD spectroscopy reveal dynamic solvation effects

View more

Chiral aminophosphonate eluent for enantiomeric analysis of amino acids

View more

Secondary phosphine oxides: tautomerism and chiral recognition monitored by multinuclear NMR spectroscopy of their Rh2[(R)-MTPA]4 adducts

View more

Chiral analysis of butaclamol enantiomers in human plasma by HPLC using a macrocyclic antibiotic (vancomycin) chiral stationary phase and solid phase extraction

View more

Enantiofacial selective reduction of 2-allyl-2-carboethoxy-cyclopentanone mediated by baker's yeast

View more

Trans-diaryl epoxides: Asymmetric synthesis, ring-opening, and absolute configuration

View more

Chiral derivatives of 2-(1-naphthyl)-2-phenylacetic acid

View more

Chiral discrimination by HPLC on aryl carbamate derivatives of chitin coated onto microporous aminopropyl silica

View more
SHOW MORE ARTICLES

Differential recognition of resveratrol isomers by the human estrogen receptor-?: Molecular dynamics evidence for stereoselective ligand binding

View more

Determination of the enantiomeric composition of mexiletine and its four hydroxylated metabolites in urine by enantioselective capillary gas chromatography

View more

Enantiomeric resolution of kielcorin derivatives by HPLC on polysaccharide stationary phases using multimodal elution

View more

Chiral effect on a self-assembling bicopper complex

View more

Use of a naphthylethylcarbamoylated-?-cyclodextrin chiral stationary phase for the separation of drug enantiomers and related compounds by sub- and supercritical fluid chromatography

View more

Enantiomeric separation of dansyl amino acids using macrocyclic antibiotics as chiral mobile phase additives by narrow-bore high-performance liquid chromatography

View more

Comparison of the chiral separation of amino-acid derivatives by a teicoplanin andRN-?-CD CSPs using waterless mobile phases: Factors that enhance resolution

View more

Enantioresolution of fluorinated diphenylmethanols and determination of their absolute configurations by X-Ray crystallographic and1H NMR anisotropy methods

View more

Assignment of absolute configuration of chiral carboxylic acids via exciton-coupled CD treatment: 4-phenylthioproline as a case study

View more

Myocardial uptake of thiopental enantiomers by the isolated perfused rat heart

View more

Enantioselective chromatography and molecular modeling of novel aryloxyaminopropan-2-ols with the alkyl carbamate function

View more

Utilizing hydrolases of opposite enantiopreference for the preparation of both enantiomers of (1R,7aR)-(?)- and (1S,7aS)-(+)-3,6,7,7a-tetrahydro-1-hydroxy-7a-methyl-1H-inden-5(2H)-one

View more

FAQS